High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$180K
$180,405
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| LUNG |
Pulmonx Corp
|
CEO
Sell to Cover
|
2026-03-02 | $96,973x3 | S | Form 4 |
|
LUNG
S
Pulmonx Corp
Lehman David Aaron
• Officer • GENERAL COUNSEL
Sell to Cover
2026-03-02
$17,499x4
|
||||||
| LUNG |
Pulmonx Corp
|
Officer • GENERAL COUNSEL
Sell to Cover
|
2026-03-02 | $17,499x4 | S | Form 4 |
|
LUNG
S
Pulmonx Corp
Radhakrishnan Srikanth
• Officer • Chief Science &Techn. Officer
Sell to Cover
2026-03-02
$14,991x4
|
||||||
| LUNG |
Pulmonx Corp
|
Officer • Chief Science &Techn. Officer
Sell to Cover
|
2026-03-02 | $14,991x4 | S | Form 4 |
|
LUNG
S
Pulmonx Corp
Rose Geoffrey Beran
• Officer • CHIEF COMMERCIAL OFFICER
Sell to Cover
2026-03-02
$11,057x4
|
||||||
| LUNG |
Pulmonx Corp
|
Officer • CHIEF COMMERCIAL OFFICER
Sell to Cover
|
2026-03-02 | $11,057x4 | S | Form 4 |
| LUNG |
Pulmonx Corp
|
CEO
Sell to Cover
|
2025-12-01 | $13,824x2 | S | Form 4 |
|
LUNG
S
Pulmonx Corp
Lehman David Aaron
• Officer • GENERAL COUNSEL
Sell to Cover
2025-12-01
$16,136x4
|
||||||
| LUNG |
Pulmonx Corp
|
Officer • GENERAL COUNSEL
Sell to Cover
|
2025-12-01 | $16,136x4 | S | Form 4 |
|
LUNG
S
Pulmonx Corp
Rose Geoffrey Beran
• Officer • CHIEF COMMERCIAL OFFICER
Sell to Cover
2025-12-01
$9,926x4
|
||||||
| LUNG |
Pulmonx Corp
|
Officer • CHIEF COMMERCIAL OFFICER
Sell to Cover
|
2025-12-01 | $9,926x4 | S | Form 4 |